PainReform Ltd
NASDAQ:PRFX
Intrinsic Value
The intrinsic value of one
PRFX
stock under the Base Case scenario is
2.12
USD.
Compared to the current market price of 0.865 USD,
PainReform Ltd
is
Undervalued by 59%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for PainReform Ltd.
Fundamental Analysis
Revenue & Expenses Breakdown
PainReform Ltd
Balance Sheet Decomposition
PainReform Ltd
| Current Assets | 3.9m |
| Cash & Short-Term Investments | 3.5m |
| Receivables | 262k |
| Other Current Assets | 168k |
| Non-Current Assets | 7.3m |
| PP&E | 84k |
| Intangibles | 7.1m |
| Other Non-Current Assets | 50k |
Free Cash Flow Analysis
PainReform Ltd
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
PainReform Ltd
|
Revenue
|
0
USD
|
|
Operating Expenses
|
-17m
USD
|
|
Operating Income
|
-17m
USD
|
|
Other Expenses
|
137k
USD
|
|
Net Income
|
-16.9m
USD
|
PRFX Profitability Score
Profitability Due Diligence
PainReform Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
PainReform Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
PRFX Solvency Score
Solvency Due Diligence
PainReform Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
PainReform Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PRFX Price Targets Summary
PainReform Ltd
Dividends
Current shareholder yield for
PRFX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PRFX
stock under the Base Case scenario is
2.12
USD.
Compared to the current market price of 0.865 USD,
PainReform Ltd
is
Undervalued by 59%.